Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:IMPR

Imprivata (IMPR) Stock Price, News & Analysis

Imprivata logo

About Imprivata Stock (NYSE:IMPR)

Advanced Chart

Key Stats

Today's Range
$19.26
$19.26
50-Day Range
N/A
52-Week Range
$9.00
$20.32
Volume
N/A
Average Volume
258,396 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

Receive IMPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imprivata and its competitors with MarketBeat's FREE daily newsletter.

IMPR Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
See More Headlines

IMPR Stock Analysis - Frequently Asked Questions

Imprivata, Inc. (NYSE:IMPR) posted its earnings results on Tuesday, February, 16th. The technology company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.10) by $0.01. The firm's revenue for the quarter was up 17.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Imprivata investors own include BioCryst Pharmaceuticals (BCRX), Teledyne FLIR (FLIR), Allegion (ALLE), Anixter International (AXE), Avigilon (AVO), Ascent Capital Group Inc Series A (ASCMA) and ASSA ABLOY AB (publ) (ASAZY).

Company Calendar

Last Earnings
2/16/2016
Today
5/06/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:IMPR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:IMPR) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners